U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189897) titled 'Apixaban or Enoxaparin After Head and Neck Cancer Surgery' on Sept. 13.
Brief Summary: The goal of this clinical trial is to learn if apixaban (a pill) is a safe and easier alternative to taking enoxaparin (a daily shot) to prevent blood clots after head and neck cancer surgery. It will also learn about side effects of both medicines.
The main questions it aims to answer are:
Can apixaban be used safely instead of enoxaparin to prevent blood clots after surgery? Do patients find apixaban easier or more satisfying to take than enoxaparin? How well do patients follow the treatment plan with each medicine?
Researchers will compare ...